These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 15946910)
1. Renal effects of gadopentetate dimeglumine in patients with normal and impaired renal function. Hoffmann U; Fischereder M; Reil A; Fischer M; Link J; Krämer BK Eur J Med Res; 2005 Apr; 10(4):149-54. PubMed ID: 15946910 [TBL] [Abstract][Full Text] [Related]
2. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Rieger J; Sitter T; Toepfer M; Linsenmaier U; Pfeifer KJ; Schiffl H Nephrol Dial Transplant; 2002 May; 17(5):824-8. PubMed ID: 11981070 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate. Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583 [TBL] [Abstract][Full Text] [Related]
4. Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in Neonates. Bedoya MA; White AM; Edgar JC; Pradhan M; Raab EL; Meyer JS Radiology; 2017 Aug; 284(2):530-540. PubMed ID: 28387639 [TBL] [Abstract][Full Text] [Related]
5. Comparison of nephrotoxicity between two gadolinium-contrasts, gadodiamide and gadopentetate in patients with mildly diminished renal failure. Naito S; Tazaki H; Okamoto T; Takeuchi K; Kan S; Takeuchi Y; Kamata K J Toxicol Sci; 2017; 42(3):379-384. PubMed ID: 28496044 [TBL] [Abstract][Full Text] [Related]
6. Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements. Zhang HL; Ersoy H; Prince MR J Magn Reson Imaging; 2006 Mar; 23(3):383-7. PubMed ID: 16463306 [TBL] [Abstract][Full Text] [Related]
7. Gadopentetate dimeglumine clearance in renal insufficiency in rabbits. Frank JA; Choyke PL; Girton ME; Morrison P; Diggs R; Skinner M Invest Radiol; 1990 Nov; 25(11):1212-6. PubMed ID: 2254055 [TBL] [Abstract][Full Text] [Related]
8. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate. Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448 [TBL] [Abstract][Full Text] [Related]
9. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Erley CM; Bader BD; Berger ED; Tuncel N; Winkler S; Tepe G; Risler T; Duda S Nephrol Dial Transplant; 2004 Oct; 19(10):2526-31. PubMed ID: 15280530 [TBL] [Abstract][Full Text] [Related]
10. Lack of nephrotoxicity of gadopentetate dimeglumine-enhanced non-vascular MRI and MRI without contrast agent in patients at high-risk for acute kidney injury. Gok Oguz E; Kiykim A; Turgutalp K; Olmaz R; Ozhan O; Muslu N; Horoz M; Bardak S; Sungur MA Med Sci Monit; 2013 Nov; 19():942-8. PubMed ID: 24193150 [TBL] [Abstract][Full Text] [Related]
11. Incidence of immediate gadolinium contrast media reactions. Prince MR; Zhang H; Zou Z; Staron RB; Brill PW AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854 [TBL] [Abstract][Full Text] [Related]
12. Change in use of gadolinium-enhanced magnetic resonance studies in kidney disease patients after US Food and Drug Administration warnings: a cross-sectional study of Veterans Affairs Health Care System data from 2005-2008. Kim KH; Fonda JR; Lawler EV; Gagnon D; Kaufman JS Am J Kidney Dis; 2010 Sep; 56(3):458-67. PubMed ID: 20580477 [TBL] [Abstract][Full Text] [Related]
13. Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure. Haustein J; Niendorf HP; Krestin G; Louton T; Schuhmann-Giampieri G; Clauss W; Junge W Invest Radiol; 1992 Feb; 27(2):153-6. PubMed ID: 1601607 [TBL] [Abstract][Full Text] [Related]